Pulmonary arterial hypertension (PAH) is a rare and chronic lung disease characterized by
progressive occlusion of the small pulmonary arteries, which is associated with structural …

Pulmonary arterial hypertension (PAH) is an enigmatic and deadly vascular disease with no
known cure. Recent years have seen rapid advances in our understanding of the molecular …

Pulmonary arterial hypertension (PAH) is a rare, progressive disorder typified by occlusion
of the pulmonary arterioles owing to endothelial dysfunction and uncontrolled proliferation of …

Pulmonary arterial hypertension (PAH) describes a group of conditions with a common
hemodynamic phenotype of increased pulmonary artery pressure, driven by progressive …

The range of cell types identified in the pathogenesis of pulmonary arterial hypertension
(PAH) has expanded substantially since the first pathological descriptions of this disease …

Background and Purpose Pulmonary arterial hypertension (PAH, type 1 pulmonary
hypertension) has a 3‐year survival of~ 50% and is in need of new, effective therapies. In …

Pulmonary artery hypertension (PAH) is a rare chronic disease with high impact on patients'
quality of life and currently no available cure. PAH is characterized by constant remodeling …

Persistent challenges in managing pulmonary vascular disease progression and poor
outcomes, despite the aggressive use of current drug therapies, highlight the need for …

Pulmonary arterial hypertension (PAH) is a disorder in which mechanical obstruction of the
pulmonary vascular bed is largely responsible for the rise in mean pulmonary arterial …

Pulmonary arterial hypertension (PAH) is a complex cardiopulmonary disease that is
associated with numerous pathogenetic molecular mechanisms and results in mixed …